Lisa Peraza
Vermögen: 107 550 $ am 30.06.2026
Vermögen: 107 550 $ am 30.06.2026
Lisa Peraza is Vice President-Finance at Connect Biopharma Holdings Ltd. since 2024.
Formerly, Ms. Peraza was Chief Accounting Officer & Vice President at Heron Therapeutics, Inc. from 2020 to 2024 and Executive Director & Controller at Ardea Biosciences, Inc. from 2008 to 2014.
Education includes undergraduate studies at the University of California, Santa Barbara.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 16.03.2026 | 45.189 ( 0,08 % ) | 107 550 $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| CONNECT BIOPHARMA HOLDINGS LIMITED | Finanzdirektor/CFO | 13.09.2024 |
| Unternehmen | Position | Ende |
|---|---|---|
| HERON THERAPEUTICS, INC. | Verwaltungsdirektor | - |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule therapeutics | Direktor/Vorstandsmitglied | 01.03.2014 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
Heron Therapeutics, Inc.
Heron Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and commercializes of polymer technologies | Health Technology |
University of California, Santa Barbara
University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule therapeutics | Health Technology |
Connect Biopharma Holdings Ltd.
Connect Biopharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen